Zydus Unveils ‘Zyrifa’: A Strategic Biosimilar that Targets Bone Health in Oncology Patients
Zydus Lifesciences Ltd., an innovation-driven global healthcare company, has announced the launch of ‘Zyrifa’, its biosimilar version of Denosumab 120 […]
CANCER-SUPPORTIVE-CARE-BIOSIMILARS
